Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New inotropic agents: milrinone analogs

P Dorigo1, D Fraccarollo, R M Gaion

  • 1Department of Pharmacology, University of Padova, Largo, Italy.

General Pharmacology
|May 1, 1997
PubMed
Summary

Two novel milrinone analogs, SF 348 and SF 349, enhance cardiac contractility. SF 348 acts via beta-adrenoceptors, while SF 349 functions by blocking adenosine A1 receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From inflammation to cytotoxicity: exposure pattern-dependent responses to alumina nanoparticles and dissolved hydrochloric acid in a human alveolar-capillary barrier model at the air-liquid interface.

Toxicology·2026
Same author

Pulmonary permeability assessment using two human lung epithelial cell models in air-liquid interface cultures.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same author

The safety of available pharmacotherapy for stroke prevention in atrial fibrillation.

Expert opinion on drug safety·2024
Same author

Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.

International journal of cardiology·2024
Same author

Effects of endurance cycling training on neuromuscular fatigue in healthy active men. Part II: Corticospinal excitability and voluntary activation.

European journal of applied physiology·2018
Same author

Effects of endurance training on neuromuscular fatigue in healthy active men. Part I: Strength loss and muscle fatigue.

European journal of applied physiology·2018

Area of Science:

  • Cardiovascular Pharmacology
  • Medicinal Chemistry

Background:

  • Milrinone analogs are investigated for their effects on cardiac contractility.
  • Understanding the mechanisms of novel positive inotropic agents is crucial for therapeutic development.

Purpose of the Study:

  • To characterize the pharmacological actions of two new milrinone analogs, SF 348 and SF 349.
  • To elucidate the specific receptor pathways involved in their positive inotropic effects.

Main Methods:

  • Isolated guinea-pig atria (spontaneously beating and electrically driven) from reserpine-treated animals were used.
  • The effects of SF 348 and SF 349 were assessed in the presence and absence of propranolol and adenosine deaminase.
  • Receptor binding studies using N6-cyclohexyl[3H]-adenosine (3H-CHA) and antagonism of N6-(R-phenylisopropyl)-adenosine (R-PIA) were performed for SF 349.

Related Experiment Videos

Main Results:

  • Both SF 348 and SF 349 increased atrial contractile activity.
  • SF 348's effect was inhibited by propranolol (beta-adrenoceptor antagonist), indicating beta-adrenoceptor involvement.
  • SF 349's activity was unaffected by propranolol but was suppressed by adenosine deaminase, and it competitively antagonized R-PIA at A1 receptors.

Conclusions:

  • SF 348 exerts its positive inotropic effect through beta-adrenoceptor activation.
  • SF 349 acts as an adenosine A1 receptor antagonist, displacing endogenous adenosine and increasing cardiac contractility.
  • These findings differentiate the mechanisms of action for novel milrinone analogs.